Literature DB >> 34188037

Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance.

Qinglei Hang1, Liyong Zeng1, Li Wang2, Litong Nie1, Fan Yao1,3, Hongqi Teng1, Yalan Deng1, Shannon Yap1, Yutong Sun4, Steven J Frank2, Junjie Chen1,5, Li Ma6,7.   

Abstract

In response to DNA double-strand breaks (DSBs), repair proteins are recruited to the damaged sites. Ubiquitin signaling plays a critical role in coordinating protein recruitment during the DNA damage response. Here, we find that the microRNA biogenesis factor DGCR8 promotes tumor resistance to X-ray radiation independently of its Drosha-binding ability. Upon radiation, the kinase ATM and the deubiquitinase USP51 mediate the activation and stabilization of DGCR8 through phosphorylation and deubiquitination. Specifically, radiation-induced ATM-dependent phosphorylation of DGCR8 at serine 677 facilitates USP51 to bind, deubiquitinate, and stabilize DGCR8, which leads to the recruitment of DGCR8 and DGCR8's binding partner RNF168 to MDC1 and RNF8 at DSBs. This, in turn, promotes ubiquitination of histone H2A, repair of DSBs, and radioresistance. Altogether, these findings reveal the non-canonical function of DGCR8 in DSB repair and suggest that radiation treatment may result in therapy-induced tumor radioresistance through ATM- and USP51-mediated activation and upregulation of DGCR8.

Entities:  

Year:  2021        PMID: 34188037     DOI: 10.1038/s41467-021-24298-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  77 in total

Review 1.  Radiation therapy for early-stage breast cancer after breast-conserving surgery.

Authors:  Thomas A Buchholz
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

Review 2.  The DNA-damage response in human biology and disease.

Authors:  Stephen P Jackson; Jiri Bartek
Journal:  Nature       Date:  2009-10-22       Impact factor: 49.962

Review 3.  Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers.

Authors:  Petra Schwertman; Simon Bekker-Jensen; Niels Mailand
Journal:  Nat Rev Mol Cell Biol       Date:  2016-05-23       Impact factor: 94.444

4.  The Future of Radiobiology.

Authors:  David G Kirsch; Max Diehn; Aparna H Kesarwala; Amit Maity; Meredith A Morgan; Julie K Schwarz; Robert Bristow; Sandra Demaria; Iris Eke; Robert J Griffin; Daphne Haas-Kogan; Geoff S Higgins; Alec C Kimmelman; Randall J Kimple; Isabelle M Lombaert; Li Ma; Brian Marples; Frank Pajonk; Catherine C Park; Dörthe Schaue; Phuoc T Tran; Eric J Bernhard
Journal:  J Natl Cancer Inst       Date:  2018-04-01       Impact factor: 13.506

5.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

Review 6.  The DNA damage response: implications for tumor responses to radiation and chemotherapy.

Authors:  Michael Goldstein; Michael B Kastan
Journal:  Annu Rev Med       Date:  2014-11-24       Impact factor: 13.739

Review 7.  Radioresistance in carcinoma of the breast.

Authors:  J K A Jameel; V S R Rao; L Cawkwell; P J Drew
Journal:  Breast       Date:  2004-12       Impact factor: 4.380

Review 8.  The DNA damage response: making it safe to play with knives.

Authors:  Alberto Ciccia; Stephen J Elledge
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

Review 9.  An Overview on Radiotherapy: From Its History to Its Current Applications in Dermatology.

Authors:  Serena Gianfaldoni; Roberto Gianfaldoni; Uwe Wollina; Jacopo Lotti; Georgi Tchernev; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2017-07-18

10.  ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.

Authors:  Peijing Zhang; Yongkun Wei; Li Wang; Bisrat G Debeb; Yuan Yuan; Jinsong Zhang; Jingsong Yuan; Min Wang; Dahu Chen; Yutong Sun; Wendy A Woodward; Yongqing Liu; Douglas C Dean; Han Liang; Ye Hu; K Kian Ang; Mien-Chie Hung; Junjie Chen; Li Ma
Journal:  Nat Cell Biol       Date:  2014-08-03       Impact factor: 28.824

View more
  1 in total

1.  Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.

Authors:  Shengshu Li; Xiaoxin Lu; Dongyang Zheng; Weizong Chen; Yuzhu Li; Fang Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-30       Impact factor: 4.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.